Direct supply from Jiangxi Baicao Pharmaceutical's automated GMP extraction facility. Qualified for pharmaceutical blending, dental pastes, and therapeutic skin care.
Gingivitis and severe periodontitis remain leading global burdens in adult oral health, driven predominantly by microbial shifts involving anaerobic biofilm architects such as Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia (the "Red Complex"). Standard therapeutic intervention requires antimicrobial and anti-inflammatory compounds capable of diffusing through polymicrobial biofilms without inducing antibiotic resistance.
Clove oil distilled from Syzygium aromaticum—standardized to ≥85.0% Eugenol (4-allyl-2-methoxyphenol)—exerts a unique multi-target biochemical action. Eugenol physically disrupts bacterial phospholipid bilayers, leading to intracellular potassium ion depletion, collapse of proton motive forces, and subsequent cell lysis. Simultaneously, its phenol moiety exerts an irreversible inhibition on cyclooxygenase-2 (COX-2), suppressing prostaglandin E2 (PGE2) synthesis in inflamed subgingival fibroblasts and halting alveolar bone resorption.
From North American operatory formulations to European regulated dental dentifrices, our OEM clove oil is customized to regional pharmacopeial standards (USP, Ph. Eur., BP).
In high-end periodontic clinics throughout the US and Germany, sterile ultrasonic irrigators utilize micro-emulsified clove oil (1.5% eugenol concentration) during scaling and root planing (SRP) procedures. This instantly suppresses bleeding on probing (BOP) and sterilizes exposed deep pockets without toxic systemic exposure.
Application: Post-Surgical & SRP LavageWidely utilized across European dental emergency rooms, clove oil combined with zinc oxide powder forms the traditional and highly reliable Zinc Oxide-Eugenol (ZOE) sedative dressing. Our ultra-purified, low-acidity grades provide consistent setting kinetics and prolonged pain suppression inside the empty extraction socket.
Grade: Heavy-Metal Tested Dental GradeMass-market retail oral hygiene across the Asia-Pacific (APAC) and Middle Eastern regions is witnessing rapid demand for herbal toothpaste and bio-adhesive gingival gels. We supply water-dispersible nano-emulsions that incorporate smoothly into silica abrasives while stabilizing volatile aromatic notes.
Consumer: Clean-Label Botanical DentifricesModern pharmaceutical delivery devices use biocompatible chitosan or cellulose films loaded with molecularly encapsulated clove oil. Applied directly onto the marginal gingiva, these patches offer sustained-release topical therapeutic dosage over an 8-to-12-hour sleeping period.
Innovation: Controlled Zero-Order ReleaseCanine and feline periodontal disease affects over 80% of pets by age three. Leading veterinary brands in North America formulate water-additive drops and enzymatic dental chews infused with low-concentration botanical clove fractions to manage halitosis and plaque build-up safely.
Formulation: Non-Irritant Pet Oral RinsesHow Jiangxi Baicao Pharmaceutical leverages proprietary industrial infrastructure, geopolitical logistics nodes, and backward raw material integration to de-risk B2B procurement.
Our 28,600 m² site houses two segregated workshops with 12 continuous extraction lines. Volatile essential oil fractionation is isolated from spray-dried botanical powders, eliminating cross-contamination risks and ensuring unaffected annual output capacity even during peak seasonal maintenance.
Situated in the Jinggangshan Economic & Technological Development Area of Jiangxi Province, our manufacturing base operates at the heart of China’s major camphoraceous and terpene processing belt. We enjoy direct multimodal access to Ningbo and Shenzhen container terminals for rapid maritime clearance.
By automating the multi-stage fractional vacuum rectification process, we achieve higher eugenol yields (up to 95% pharmaceutical grade) with 22% less thermal energy consumption. These process efficiencies shield global enterprise buyers from raw botanical market price volatility.
Every lot of imported clove buds undergoes botanical DNA identification, moisture determination, and pesticide multiresidue screening.
Low-temperature steam rectification isolates high-boiling eugenol fractions while separating heavy tar fractions and volatile terpene adulterants.
Verification across three in-house platforms: GC-MS for chemical fingerprinting, HPLC for polyphenolic quantification, and ICP-MS for heavy metals.
Filled into PVDF-lined steel drums or pharmaceutical glass containers under medical-grade nitrogen gas headspace to stop oxidation.
Verified batch parameters comparing Baicao Pharmaceutical Grade Clove Oil against USP (United States Pharmacopeia) & Ph. Eur. standards.
| Analytical Assay Parameter | USP / EP Monograph Limit | Baicao Pharma In-House Standard | Instrumental Method |
|---|---|---|---|
| Eugenol Content (Assay) | 85.0% – 95.0% | 88.0% – 92.5% (Controlled) | GC-FID (Chiral Capillary Column) |
| Refractive Index (20°C) | 1.528 to 1.537 | 1.530 to 1.535 | Digital Automated Refractometer |
| Specific Gravity (25°C) | 1.038 to 1.060 | 1.042 to 1.054 | Oscillating U-Tube Densitometer |
| Eugenyl Acetate & Caryophyllene | Conforms to reference spectrum | Eugenyl Acetate: 4–10% | Caryophyllene: 2–7% | GC-MS Fingerprint Archive |
| Heavy Metals (Pb, As, Cd, Hg) | < 10.0 ppm cumulative | < 0.5 ppm Total (Undetectable Hg) | ICP-MS (Triple Quadrupole) |
| Residual Solvents (USP <467>) | Class 1, 2, 3 Below ICH limits | Zero Organic Solvents (Steam Only) | Headspace Gas Chromatography |
| Microbiological Contamination | TAMC <100 CFU/g, TYMC <10 CFU/g | Sterile Equivalent / Absence in 10g | Membrane Filtration USP <61> |
Micro-encapsulated water-soluble clove powders engineered to eliminate mucosal stinging sensations in paediatric and geriatric mouthwash formulations.
Enhancing targeted periodontal pocket penetration, allowing lower eugenol concentrations to achieve identical bactericidal efficacy with prolonged residence time.
Next-generation zero-thermal extraction to retain fragile secondary sesquiterpenes that act synergistically against periodontal anaerobic pathogens.
Navigating multinational pharmaceutical registrations, allergen threshold declarations, and global import requirements with complete dossier support.
In the United States, eugenol is cataloged under the FDA OTC Oral Health-Care Drug Products Monograph (21 CFR Part 356) as an approved toothache relief agent. Baicao provides comprehensive Type IV Drug Master File (DMF) technical packages, stability test dossiers (ICH Q1A), and analytical validation reports to fast-track FDA submissions.
Within the European Union (Regulation (EC) No 1223/2009), eugenol is classified as an identifiable fragrance allergen (Annex III). We supply complete quantitative compositional sheets, Certificate of Analysis (COA) certificates disclosing exact percentage thresholds, and IFRA 50th Amendment documentation for seamless CPNP notification.
Meeting the expanding demand for alcohol-free oral hygiene products across the GCC nations and Southeast Asia (MUI Halal / JAKIM standards). Our 100% pure steam-distilled clove oil contains zero ethanol, animal by-products, or processing aids, facilitating immediate local ministry certifications.
In-depth responses regarding chemical stabilization, OEM production lead times, minimum order quantities, and clinical safety parameters.
Explore our extended series of therapeutic carrier oils, aromatic distillates, and premium plant essences engineered for multinational brand supply.